Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
1.530
-0.013 (-0.87%)
At close: Jun 10, 2026
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $10.94 million as of June 10, 2026. Its market cap has decreased by -16.11% in one year.
Market Cap
10.94M
Enterprise Value
14.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.53
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.35M to 10.94M, a decrease of -51.04%. That is a compound annual growth rate of -3.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 11.04M | 90.54% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anebulo Pharmaceuticals | 15.29M |
| Galera Therapeutics | 15.24M |
| Zeo ScientifiX | 14.15M |
| Inhibitor Therapeutics | 13.38M |
| ZIVO Bioscience | 12.66M |
| Finch Therapeutics Group | 11.96M |
| Reviva Pharmaceuticals Holdings | 9.37M |
| Biomind Labs | 9.31M |